Abstract
Resmetirom (MGL-3196) is an oral, liver-directed, selective thyroid hormone receptor beta agonist. It regulates metabolic pathways in the liver that
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have